Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Selected Articles from This Issue

DOI:  Published October 2020
  • Article
  • Info & Metrics
  • PDF
Loading

County-Level Persistent Poverty and Cancer Mortality Rates

Moss et al. Page 1949

Moss and colleagues assessed disparities in cancer mortality by county-level persistent poverty, that is, whether counties continuously experienced high levels of poverty since 1980. The authors merged 2007 to 2011 data from the National Center for Health Statistics (cancer mortality rates) and American Community Survey (poverty classifications). Overall cancer mortality rates were 12.3% higher in persistent poverty counties versus all others, and 9.6% higher in persistent versus current poverty counties, with even greater disparities observed for specific cancer sites. Persistent poverty counties have exceptionally high cancer mortality, and targeted research, policy, and intervention efforts are needed to reduce these geographic disparities in cancer.

Higher Plasma Amyloid-Beta Levels Are Associated with a Higher Risk of Cancer

van der Willik et al. Page 1993

Many studies have shown that patients with Alzheimer disease are at decreased risk of cancer, but this inverse relation is likely to be biased by surveillance and survival bias. To overcome such bias, van der Willik and colleagues determined the relation between plasma amyloid-β levels—a preclinical feature of Alzheimer disease—and the risk of cancer in a population-based setting. They showed that higher levels of plasma amyloid-β were associated with a higher risk of cancer, suggesting a potential biological link between Alzheimer disease and cancer. The pathophysiologic role of amyloid-β in cancer and its causality warrant further investigation.

SEMs Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell Neoplasms

Gagliardi et al. Page 2026

The total number of stochastic epigenetic mutations (SEM) has been proposed as a biomarker of accumulation of exposure-related DNA damage, but its predictive role in cancer has scarcely been studied. In three prospective cohorts including eight types of cancer, the total number of SEMs was associated with increased risk of breast, lung, and mature B-cell cancers in pre-diagnostic blood samples. Extreme outliers of methylation levels seem to occur more often in functional genomic regions regulated by components of the PRC2 complex. Identified SEMs suggest a possible carcinogenesis mechanism and may represent a potential biomarker for cancer early detection.

Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer

Yin et al. Page 2057

The study conducted by Yin and colleagues was a case–control study nested in the Linxian Nutrition Intervention Trial cohorts with over 22-years of follow-up, which evaluated the independent and joint associations between serum calcium, 25-hydroxy vitamin D, and the risk of primary liver cancer prospectively at the first time. Low and high serum calcium resulted in increased risk, whereas high serum 25(OH)D was a protective factor. In a nutrient-deficient population, serum calcium and 25(OH)D could potentially be modifiable risk or protective factors, providing potential targets for primary liver cancer prevention and control.

  • ©2020 American Association for Cancer Research.
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 29 (10)
October 2020
Volume 29, Issue 10
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selected Articles from This Issue
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Selected Articles from This Issue
Cancer Epidemiol Biomarkers Prev October 1 2020 (29) (10) 1841;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Selected Articles from This Issue
Cancer Epidemiol Biomarkers Prev October 1 2020 (29) (10) 1841;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • County-Level Persistent Poverty and Cancer Mortality Rates
    • Higher Plasma Amyloid-Beta Levels Are Associated with a Higher Risk of Cancer
    • SEMs Are Associated with Risk of Breast Cancer, Lung Cancer, and Mature B-cell Neoplasms
    • Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement